Loading data
ALXONasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 77 m USD | 116.37 m USD | 141.8 m USD | 98.4 m USD | 60.17 m USD |
| Operating profit | -104.02 m USD | -142.47 m USD | -170.28 m USD | -127.44 m USD | -83.56 m USD |
| Interest expense | 1.6 m USD | 1.73 m USD | 1.57 m USD | 238 k USD | 13 k USD |
| Profit before tax | -101.7 m USD | -134.85 m USD | -160.81 m USD | -123.42 m USD | -83.48 m USD |
| Income tax expense | 0 USD | 0 USD | 0 USD | 64 k USD | -21 k USD |
| Net income (reported basis) | -101.7 m USD | -134.85 m USD | -160.81 m USD | -123.48 m USD | -83.46 m USD |
| Net income attributable to common shareholders | — | — | — | -123.48 m USD | -83.46 m USD |
| Basic earnings per share | -1.9 USD/share | -2.58 USD/share | -3.74 USD/share | -3.03 USD/share | -2.07 USD/share |
| Diluted earnings per share | -1.9 USD/share | -2.58 USD/share | -3.74 USD/share | -3.03 USD/share | -2.07 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.